These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 25626701)
21. Myocardial (123)I-MIBG scintigraphy for differentiation of Lewy bodies disease from FTD. Novellino F; Bagnato A; Salsone M; Cascini GL; Nicoletti G; Arabia G; Pugliese P; Morelli M; Paglionico S; Cipullo S; Manna I; De Marco EV; Condino F; Chiriaco C; Morgante L; Zappia M; Quattrone A Neurobiol Aging; 2010 Nov; 31(11):1903-11. PubMed ID: 19135762 [TBL] [Abstract][Full Text] [Related]
22. Myocardial scintigraphy may predict the conversion to probable dementia with Lewy bodies. Oda H; Ishii K; Terashima A; Shimada K; Yamane Y; Kawasaki R; Ohkawa S Neurology; 2013 Nov; 81(20):1741-5. PubMed ID: 24122183 [TBL] [Abstract][Full Text] [Related]
23. Diagnostic Sensitivity and Symptomatic Relevance of Dopamine Transporter Imaging and Myocardial Sympathetic Scintigraphy in Patients with Dementia with Lewy Bodies. Tang Z; Hirano S; Koizumi Y; Izumi M; Kitayama Y; Yamagishi K; Tamura M; Ishikawa A; Kashiwado K; Iimori T; Mukai H; Yokota H; Horikoshi T; Uno T; Kuwabara S J Alzheimers Dis; 2024; 100(1):127-137. PubMed ID: 38848178 [TBL] [Abstract][Full Text] [Related]
24. Comparison of parameters of (123)I-metaiodobenzylguanidine scintigraphy for differential diagnosis in patients with parkinsonism: correlation with clinical features. Uchiyama Y; Momose M; Kondo C; Kusakabe K; Uchiyama S Ann Nucl Med; 2011 Aug; 25(7):478-85. PubMed ID: 21499991 [TBL] [Abstract][Full Text] [Related]
25. [Improved diagnosis of dementia with Lewy bodies by the combination of 123I-metaiodobenzylguanidine (MIBG) myocardial scintigraphy and 99mTc-ethylcysteinate dimmer (ECD) brain perfusion SPECT]. Kobayashi S; Tateno M; Furukawa Y; Shirasaka T; Utumi K Seishin Shinkeigaku Zasshi; 2008; 110(4):285-91. PubMed ID: 18593002 [TBL] [Abstract][Full Text] [Related]
26. Pure psychiatric presentation of the Lewy body disease is depression--an analysis of 60 cases verified with myocardial meta-iodobenzylguanidine study. Kobayashi K; Nakano H; Akiyama N; Maeda T; Yamamori S Int J Geriatr Psychiatry; 2015 Jun; 30(6):663-8. PubMed ID: 25335897 [TBL] [Abstract][Full Text] [Related]
27. Development of an Kamiya Y; Ota S; Tanaka Y; Yamashita K; Takaki A; Ito S Asia Ocean J Nucl Med Biol; 2018; 6(2):129-138. PubMed ID: 29998146 [TBL] [Abstract][Full Text] [Related]
28. Comparison of the diagnostic performance of H/M ratio between early and delayed phases for Lewy body disease. Maruyama Y; Yamada T; Murakami K; Kumano R Nucl Med Commun; 2015 May; 36(5):477-80. PubMed ID: 25714666 [TBL] [Abstract][Full Text] [Related]
29. [Utility of early imaging of myocardial innervation scintigraphy in the diagnosis of Lewy Body Dementia]. Camacho V; Estorch M; Marquié M; Domènech A; Flotats A; Fernández A; Duch J; Geraldo LL; Deportos J; Artigas C; Lleó A; Carrió I Rev Esp Med Nucl Imagen Mol; 2013 Mar; 32(2):77-80. PubMed ID: 23177334 [TBL] [Abstract][Full Text] [Related]
30. Cardiac sympathetic impairment parallels nigrostriatal degeneration in Probable Dementia with Lewy Bodies. Camacho V; Marquié M; Lleó A; Alvés L; Artigas C; Flotats A; Duch J; Blesa R; Gómez-Isla T; Carrió I; Estorch M Q J Nucl Med Mol Imaging; 2011 Aug; 55(4):476-83. PubMed ID: 21150861 [TBL] [Abstract][Full Text] [Related]
31. Early diagnosis of Lewy body disease in patients with late-onset psychiatric disorders using clinical history of rapid eye movement sleep behavior disorder and [ Fujishiro H; Okuda M; Iwamoto K; Miyata S; Torii Y; Iritani S; Ozaki N Psychiatry Clin Neurosci; 2018 Jun; 72(6):423-434. PubMed ID: 29536584 [TBL] [Abstract][Full Text] [Related]
32. 123I-ioflupane brain SPECT and 123I-MIBG cardiac planar scintigraphy combined use in uncertain parkinsonian disorders. Nuvoli S; Spanu A; Piras MR; Nieddu A; Mulas A; Rocchitta G; Galleri G; Serra PA; Madeddu G Medicine (Baltimore); 2017 May; 96(21):e6967. PubMed ID: 28538394 [TBL] [Abstract][Full Text] [Related]
33. Diagnostic value of MIBG cardiac scintigraphy for differential dementia diagnosis. Slaets S; Van Acker F; Versijpt J; Hauth L; Goeman J; Martin JJ; De Deyn PP; Engelborghs S Int J Geriatr Psychiatry; 2015 Aug; 30(8):864-9. PubMed ID: 25363642 [TBL] [Abstract][Full Text] [Related]
34. Comparison of (123)I-MIBG myocardial scintigraphy, brain perfusion SPECT, and voxel-based MRI morphometry for distinguishing between dementia with Lewy bodies and Alzheimer's disease. Inui Y; Toyama H; Manabe Y; Sarai M; Iwata N Ann Nucl Med; 2014 Oct; 28(8):796-804. PubMed ID: 24986482 [TBL] [Abstract][Full Text] [Related]
35. Sympathetic Nakajima K; Matsumura T; Komatsu J; Wakabayashi H; Ono K; Kinuya S Ann Nucl Med; 2024 Oct; 38(10):814-824. PubMed ID: 38869809 [TBL] [Abstract][Full Text] [Related]
36. 123I-metaiodobenzylguanidine myocardial scintigraphy with early images alone is useful for the differential diagnosis of dementia with Lewy bodies. Manabe Y; Inui Y; Toyama H; Kosaka K Psychiatry Res Neuroimaging; 2017 Mar; 261():75-79. PubMed ID: 28152401 [TBL] [Abstract][Full Text] [Related]
37. [Dementia with Lewy bodies and Alzheimer's disease: differential diagnosis by cardiac sympathetic innervation MIBG imaging]. Estorch M; Camacho V; Fuertes J; Rodríguez-Revuelto A; Hernández MA; Flotats A; Kulisevsky J; Carrió I Rev Esp Med Nucl; 2006; 25(4):229-35. PubMed ID: 16827985 [TBL] [Abstract][Full Text] [Related]
38. Detection of Lewy body disease in patients with late-onset depression, anxiety and psychotic disorder with myocardial meta-iodobenzylguanidine scintigraphy. Kobayashi K; Sumiya H; Nakano H; Akiyama N; Urata K; Koshino Y Int J Geriatr Psychiatry; 2010 Jan; 25(1):55-65. PubMed ID: 19637401 [TBL] [Abstract][Full Text] [Related]
39. Meta-analysis of 123I-MIBG cardiac scintigraphy for the diagnosis of Lewy body-related disorders. King AE; Mintz J; Royall DR Mov Disord; 2011 Jun; 26(7):1218-24. PubMed ID: 21480373 [TBL] [Abstract][Full Text] [Related]
40. First determination of the heart-to-mediastinum ratio using cardiac dual isotope (¹²³I-MIBG/⁹⁹mTc-tetrofosmin) CZT imaging in patients with heart failure: the ADRECARD study. Bellevre D; Manrique A; Legallois D; Bross S; Baavour R; Roth N; Blaire T; Desmonts C; Bailliez A; Agostini D Eur J Nucl Med Mol Imaging; 2015 Nov; 42(12):1912-9. PubMed ID: 26227533 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]